Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.31%66.8522.0%$202.67m
ZGNXZogenix, Inc.
1.64%38.7316.8%$131.61m
SHPGShire PLC Sponsored ADR
-3.38%146.910.4%$117.41m
VRXValeant Pharmaceuticals International, Inc.
-3.37%12.3814.2%$102.09m
PRGOPerrigo Co. Plc
-0.55%88.096.5%$92.89m
AERIAerie Pharmaceuticals, Inc.
-0.19%64.488.6%$65.67m
MNKMallinckrodt Plc
-0.23%32.2917.7%$57.10m
CTLTCatalent Inc
1.36%42.122.7%$57.02m
PTLAPortola Pharmaceuticals, Inc.
-0.28%50.367.9%$52.54m
JAZZJazz Pharmaceuticals Plc
-0.22%140.192.2%$51.13m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.02%110.837.6%$49.30m
UTHRUnited Therapeutics Corporation
-0.30%121.4214.4%$46.91m
ENDPEndo International Plc
-0.39%7.618.9%$38.95m
SUPNSupernus Pharmaceuticals, Inc.
0.18%41.136.4%$37.71m
HZNPHorizon Pharma plc
0.44%13.847.6%$36.35m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.